Select Page

Atrin Pharmaceuticals Elects Jeffrey M. Dayno

Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD to Board of Directors Doylestown, PA (November 16, 2016):  Atrin Pharmaceuticals, LLC. today announced the election of Jeffrey M. Dayno, M.D., chief medical officer of Egalet Corporation, to the Atrin Board of...

Atrin Pharmaceuticals Appoints Gerhard J. Sperl

Atrin Pharmaceuticals Appoints Gerhard J. Sperl, Ph.D. as Vice President, Chemistry, Manufacturing and Controls Doylestown, PA (October 25, 2016):  Atrin Pharmaceuticals, LLC. today announced the appointment of Gerhard J. Sperl, Ph.D., as Vice President, Chemistry,...

Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract

Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract for Development of Highly Specific ATR inhibitors for Targeted Cancer Treatment Doylestown, PA (October 19, 2016):  Atrin Pharmaceuticals, Inc. today announced receipt of a Phase 1 Small Business Technology...

Ben Franklin Approves Funding

Ben Franklin approves funding for Atrin Pharmaceuticals Ben Franklin approves $2M for 10 Early Stage Companies across South Eastern PA